Norway has been selected as the Screening Campaign Country for February 2025. This initiative rotates monthly among different EU member countries, each sharing updates and initiatives to enhance cancer screening practices and participation.
Throughout the month of February 2025, Norway will highlight the work being done at the Cancer Registry of Norway to improve communication around cancer screening.
The Norwegian Institute of Public Health (NIPH) are leading the following Work Packages and Tasks within the EUCanScreen Joint Action:
Work Package 6 (WP6) Addressing Barriers and Facilitators in Cancer Screening, led by Mari Nygård – Head of the Department of Research at the Cancer Registry of Norway. In collaboration with 26 EU countries, this package aims to identify and overcome barriers to participation in cancer screening programs. The focus is on developing tools and strategies that ensure equal access to life-saving screenings across Europe.
Task 6.4 Addressing barriers in immigrant populations, led by Mari Nygård.
Task 11.5 Cervical cancer screening specialist training and regional training centre, led by Ameli Tropé – Head of CervicalScreen Norway at the Cancer Registry of Norway.
This Task is under Work Package 11 Capacity building, where the overall objective is to empower current and future leaders of cancer screening in exemplary countries to successfully implement or improve organised population-based screening in their respective countries.
A dedicated team of 17 members from the Cancer Registry of Norway is contributing to this initiative, with a total dedication of 111.5 personal months.
Throughout February, Norway will share:
Join us this month as we showcase Norway’s contributions to making cancer screening more accessible and effective across Europe.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959